Table 5 Subgroup analyses: modified Rankin Scale (mRS) at baseline, 3 and 6 months and mRS change scores, according to baseline NIHSS score in 306 ESD Stroke Bergen study patients
Baseline NIHSS score | ESD 1 group | ESD 2 group | Control group | p-value* | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
NIHSS 0–1 (n = 88); mean (SD) (n) | ||||||||||
Baseline | 1.64 | (0.99) | (28) | 1.96 | (1.02) | (25) | 1.83 | (1.12) | (35) | 0.561 |
3 months | 1.45 | (0.96) | (22) | 2.05 | (0.95) | (22) | 1.96 | (1.15) | (26) | 0.109 |
6 months | 1.32 | (1.09) | (22) | 2.25 | (0.79) | (20) | 2.00 | (1.65) | (20) | 0.016 |
Change score 0–3 months | −0.36 | (0.85) | (22) | 0.05 | (1.13) | (22) | 0.23 | (1.34) | (26) | 0.187 |
Change score 0–6 months | −0.27 | (1.08) | (22) | 0.20 | (1.11) | (20) | 0.20 | (1.67) | (20) | 0.424 |
NIHSS 2–4 (n = 130); mean (SD) (n) | ||||||||||
Baseline | 2.35 | (1.06) | (48) | 2.17 | (0.93) | (46) | 2.50 | (0.85) | (36) | 0.424 |
3 months | 2.32 | (1.34) | (34) | 1.74 | (1.33) | (38) | 2.09 | (0.90) | (23) | 0.059 |
6 months | 2.40 | (1.33) | (35) | 1.83 | (1.42) | (35) | 2.25 | (0.99) | (24) | 0.049 |
Change score 0–3 months | −0.18 | (1.00) | (34) | −0.47 | (1.22) | (38) | −0.22 | (0.80) | (23) | 0.202 |
Change score 0–6 months | −0.11 | (0.99) | (35) | −0.37 | (1.44) | (35) | −0.08 | (0.83) | (24) | 0.238 |
NIHSS ≥5 (n = 86); mean (SD) (n) | ||||||||||
Baseline | 3.74 | (1.02) | (27) | 3.64 | (0.74) | (33) | 3.88 | (0.71) | (26) | 0.391 |
3 months | 3.46 | (1.33) | (26) | 3.24 | (1.21) | (29) | 4.00 | (1.21) | (20) | 0.114 |
6 months | 3.38 | (1.53) | (24) | 3.44 | (1.37) | (27) | 3.95 | (1.23) | (20) | 0.411 |
Change score 0–3 months | −0.27 | (0.92) | (26) | −0.52 | (1.21) | (29) | 0.00 | (0.97) | (20) | 0.168 |
Change score 0–6 months | −0.38 | (1.21) | (24) | −0.22 | (1.40) | (27) | −0.05 | (1.05) | (20) | 0.813 |